Rocket Pharmaceuticals RCKT
NASDAQ RCKT
$2.31 +0.11 (+5.00%)
At close: Oct 22, 2026 · 4:00 PM EDT

Rocket Pharmaceuticals (RCKT) EV to CFO (2017)

Updated

Rocket Pharmaceuticals' EV to CFO was -5.13 in Q3 2017.

Analysis

Rocket Pharmaceuticals (RCKT) EV to CFO (2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn
10 Rocket Pharmaceuticals 253.04 Mn -30.66 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2017 -5.13
Jun 30, 2017 -10.23
API Access

Rocket Pharmaceuticals EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=RCKT&period=max&api_key=YOUR_API_KEY